Sieving through the cancer secretome

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 11, 2013, Pages 2360-2371

  Lin, Qifeng ^a   Tan, Hwee Tong ^a   Lim, Hannah Soo Rei ^b   Chung, Maxey C M ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomarker; Cancer; Proteomics; Secreted protein; Secretome

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA FETOPROTEIN; BETA ACTIN; BETA TUBULIN; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CANCER SECRETOME; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN L; CD14 ANTIGEN; CELL PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; COMPLEMENT COMPONENT C4B BINDING PROTEIN; CYSTATIN M; FETUIN A; GELATINASE A; GROWTH DIFFERENTIATION FACTOR 15; HERMES ANTIGEN; INTERLEUKIN 18; LAMININ; LECTIN; METALLOPROTEINASE; PLASMA PROTEIN; PLEXIN; SEMAPHORIN; SOMATOMEDIN BINDING PROTEIN 2; STROMAL CELL DERIVED FACTOR 1; TISSUE POLYPEPTIDE ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ALPHA FETOPROTEIN BLOOD LEVEL; AUTOLYSIS; AUTORADIOGRAPHY; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORTALITY; CARBOHYDRATE ANALYSIS; CELL CULTURE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHEMICAL LABELING; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CYTOLYSIS; DIAGNOSTIC VALUE; DOWN REGULATION; EXOSOME; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LYMPH NODE METASTASIS; MEMBRANE VESICLE; METASTASIS; MOLECULAR WEIGHT; MOUTH SQUAMOUS CELL CARCINOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; T CELL LYMPHOMA; THYROID CANCER; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

BIOMARKER; CANCER; PROTEOMICS; SECRETED PROTEIN; SECRETOME;

ANIMALS; HUMANS; NEOPLASMS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884674295     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.01.030     Document Type: Review

References (112)

1. F. Bray, J.S. Ren, E. Masuyer, and J. Ferlay Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Int. J. Cancer 132 2012 1133 1145
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
3. M.P. Pavlou, and E.P. Diamandis The cancer cell secretome: a good source for discovering biomarkers? J. Proteomics 73 2010 1896 1906
4. H. Zhang, and D.W. Chan Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach Cancer Epidemiol. Biomark. Prev. 16 2007 1915 1917 (Pubitemid 47621162)
5. H. Tjalsma, A. Bolhuis, J.D. Jongbloed, S. Bron, and J.M. van Dijl Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome Microbiol. Mol. Biol. Rev. 64 2000 515 547
6. G.S. Karagiannis, M.P. Pavlou, and E.P. Diamandis Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology Mol. Oncol. 4 2010 496 510
7. W. Nickel The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes Eur. J. Biochem. 270 2003 2109 2119 (Pubitemid 36608925)
8. R.J. Simpson, S.S. Jensen, and J.W. Lim Proteomic profiling of exosomes: current perspectives Proteomics 8 2008 4083 4099
9. M. Makridakis, and A. Vlahou Secretome proteomics for discovery of cancer biomarkers J. Proteomics 73 2010 2291 2305
10. S. Cooper Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points FASEB J. 17 2003 333 340 (Pubitemid 36292949)
11. J.S. Shin, S.W. Hong, S.L. Lee, T.H. Kim, I.C. Park, S.K. An, W.K. Lee, J.S. Lim, K.I. Kim, Y. Yang, S.S. Lee, D.H. Jin, and M.S. Lee Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells Int. J. Oncol. 32 2008 435 439 (Pubitemid 351188310)
12. N.M. Hasan, G.E. Adams, and M.C. Joiner Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: implications for cell death Int. J. Cancer 80 1999 400 405 (Pubitemid 29019627)
13. L. Zander, and M. Bemark Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line Cell Prolif. 41 2008 136 155
14. M. Colzani, P. Waridel, J. Laurent, E. Faes, C. Ruegg, and M. Quadroni Metabolic labeling and protein linearization technology allow the study of proteins secreted by cultured cells in serum-containing media J. Proteome Res. 8 2009 4779 4788
15. K. Eichelbaum, M. Winter, M.B. Diaz, S. Herzig, and J. Krijgsveld Selective enrichment of newly synthesized proteins for quantitative secretome analysis Nat. Biotechnol. 2012
16. P. Dowling, and M. Clynes Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers Proteomics 11 2011 794 804
17. F. Mbeunkui, O. Fodstad, and L.K. Pannell Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS J. Proteome Res. 5 2006 899 906
18. C.G. Gunawardana, C. Kuk, C.R. Smith, I. Batruch, A. Soosaipillai, and E.P. Diamandis Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer J. Proteome Res. 8 2009 4705 4713
19. V. Kulasingam, and E.P. Diamandis Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets Mol. Cell. Proteomics 6 2007 1997 2011 (Pubitemid 350201873)
20. G. Sardana, K. Jung, C. Stephan, and E.P. Diamandis Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers J. Proteome Res. 7 2008 3329 3338
21. H. Zwickl, E. Traxler, S. Staettner, W. Parzefall, B. Grasl-Kraupp, J. Karner, R. Schulte-Hermann, and C. Gerner A novel technique to specifically analyze the secretome of cells and tissues Electrophoresis 26 2005 2779 2785 (Pubitemid 41078987)
22. H. Loei, H.T. Tan, T.K. Lim, K.H. Lim, J.B. So, K.G. Yeoh, and M.C. Chung Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer J. Proteome Res. 11 2012 1759 1772
23. M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry, A.P. Davis, K. Dolinski, S.S. Dwight, J.T. Eppig, M.A. Harris, D.P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J.C. Matese, J.E. Richardson, M. Ringwald, G.M. Rubin, and G. Sherlock Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 25 2000 25 29 (Pubitemid 30257031)
24. V.N. Bhatia, D.H. Perlman, C.E. Costello, and M.E. McComb Software tool for researching annotations of proteins: open-source protein annotation software with data visualization Anal. Chem. 81 2009 9819 9823
25. H. Mi, B. Lazareva-Ulitsky, R. Loo, A. Kejariwal, J. Vandergriff, S. Rabkin, N. Guo, A. Muruganujan, O. Doremieux, M.J. Campbell, H. Kitano, and P.D. Thomas The PANTHER database of protein families, subfamilies, functions and pathways Nucleic Acids Res. 33 2005 D284 D288
26. C. Guda, and S. Subramaniam pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes Bioinformatics 21 2005 3963 3969 (Pubitemid 41631835)
27. C. Guda pTARGET: a web server for predicting protein subcellular localization Nucleic Acids Res. 34 2006 W210 W213
28. S. Briesemeister, T. Blum, S. Brady, Y. Lam, O. Kohlbacher, and H. Shatkay SherLoc2: a high-accuracy hybrid method for predicting subcellular localization of proteins J. Proteome Res. 8 2009 5363 5366
29. H.N. Lin, C.T. Chen, T.Y. Sung, S.Y. Ho, and W.L. Hsu Protein subcellular localization prediction of eukaryotes using a knowledge-based approach BMC Bioinforma. 10 Suppl. 15 2009 S8
30. E.W. Klee, and C.P. Sosa Computational classification of classically secreted proteins Drug Discov. Today 12 2007 234 240
31. T.N. Petersen, S. Brunak, G. von Heijne, and H. Nielsen SignalP 4.0: discriminating signal peptides from transmembrane regions Nat. Methods 8 2011 785 786
32. M. Boden, and J. Hawkins Prediction of subcellular localization using sequence-biased recurrent networks Bioinformatics 21 2005 2279 2286 (Pubitemid 40731580)
33. Y. Chen, Y. Zhang, Y. Yin, G. Gao, S. Li, Y. Jiang, X. Gu, and J. Luo SPD - a web-based secreted protein database Nucleic Acids Res. 33 2005 D169 D173
34. J.D. Bendtsen, L.J. Jensen, N. Blom, G. Von Heijne, and S. Brunak Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 17 2004 349 356 (Pubitemid 39093515)
35. S. Mathivanan, C.J. Fahner, G.E. Reid, and R.J. Simpson ExoCarta 2012: database of exosomal proteins, RNA and lipids Nucleic Acids Res. 40 2012 D1241 D1244
36. B. Muthusamy, G. Hanumanthu, S. Suresh, B. Rekha, D. Srinivas, L. Karthick, B.M. Vrushabendra, S. Sharma, G. Mishra, P. Chatterjee, K.S. Mangala, H.N. Shivashankar, K.N. Chandrika, N. Deshpande, M. Suresh, N. Kannabiran, V. Niranjan, A. Nalli, T.S. Prasad, K.S. Arun, R. Reddy, S. Chandran, T. Jadhav, D. Julie, M. Mahesh, S.L. John, K. Palvankar, D. Sudhir, P. Bala, N.S. Rashmi, G. Vishnupriya, K. Dhar, S. Reshma, R. Chaerkady, T.K. Gandhi, H.C. Harsha, S.S. Mohan, K.S. Deshpande, M. Sarker, and A. Pandey Plasma Proteome Database as a resource for proteomics research Proteomics 5 2005 3531 3536 (Pubitemid 41192058)
37. T. Farrah, E.W. Deutsch, G.S. Omenn, D.S. Campbell, Z. Sun, J.A. Bletz, P. Mallick, J.E. Katz, J. Malmstrom, R. Ossola, J.D. Watts, B. Lin, H. Zhang, R.L. Moritz, and R. Aebersold A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol. Cell. Proteomics 10 2011 M110 (006353)
38. J. Cao, Y. Hu, C. Shen, J. Yao, L. Wei, F. Yang, A. Nie, H. Wang, H. Shen, Y. Liu, Y. Zhang, Y. Tang, and P. Yang Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells Proteomics 9 2009 4881 4888
39. H.Y. Wu, Y.H. Chang, Y.C. Chang, and P.C. Liao Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry J. Proteome Res. 8 2009 380 389
40. Y.H. Chang, C.C. Wu, K.P. Chang, J.S. Yu, Y.C. Chang, and P.C. Liao Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma J. Proteome Res. 8 2009 5465 5474
41. M. Stastna, and J.E. Van Eyk Secreted proteins as a fundamental source for biomarker discovery Proteomics 12 2012 722 735
42. C.M. Huang, C.C. Wang, M. Kawai, S. Barnes, and C.A. Elmets In vivo protein sampling using capillary ultrafiltration semi-permeable hollow fiber and protein identification via mass spectrometry-based proteomics J. Chromatogr. A 1109 2006 144 151 (Pubitemid 43358035)
43. C.M. Huang, H.N. Ananthaswamy, S. Barnes, Y. Ma, M. Kawai, and C.A. Elmets Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses Proteomics 6 2006 6107 6116 (Pubitemid 44851395)
44. J.W. Chang, U.B. Kang, D.H. Kim, J.K. Yi, J.W. Lee, D.Y. Noh, C. Lee, and M.H. Yu Identification of circulating endorepellin LG3 fragment: potential use as a serological biomarker for breast cancer Proteomics Clin. Appl. 2 2008 23 32 (Pubitemid 351210913)
45. J.E. Kim, K.H. Koo, Y.H. Kim, J. Sohn, and Y.G. Park Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model Exp. Mol. Med. 40 2008 709 720
46. A.M. Mlynarek, R.L. Balys, J. Su, M.P. Hier, M.J. Black, and M.A. Alaoui-Jamali A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma Arch. Otolaryngol. Head Neck Surg. 133 2007 910 918 (Pubitemid 47437279)
47. B. Pang, H. Zhang, J. Wang, W.Z. Chen, S.H. Li, Q.G. Shi, R.X. Liang, B.X. Xie, R.Q. Wu, X.L. Qian, L. Yu, Q.M. Li, C.F. Huang, and J.G. Zhou Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression Prostate 69 2009 1176 1187
48. N.S. Vasudev, S. Sim, D.A. Cairns, R.E. Ferguson, R.A. Craven, A. Stanley, J. Cartledge, D. Thompson, P.J. Selby, and R.E. Banks Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma Br. J. Cancer 101 2009 1175 1182
49. A. Iannetti, F. Pacifico, R. Acquaviva, A. Lavorgna, E. Crescenzi, C. Vascotto, G. Tell, A.M. Salzano, A. Scaloni, E. Vuttariello, G. Chiappetta, S. Formisano, and A. Leonardi The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells Proc. Natl. Acad. Sci. U. S. A. 105 2008 14058 14063
50. L. Monteoliva, and J.P. Albar Differential proteomics: an overview of gel and non-gel based approaches Brief. Funct. Genomic. Proteomic. 3 2004 220 239
51. C. Planque, V. Kulasingam, C.R. Smith, K. Reckamp, L. Goodglick, and E.P. Diamandis Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteomics 8 2009 2746 2758
52. B.J. Xu, W. Yan, B. Jovanovic, A.Q. An, N. Cheng, M.E. Aakre, Y. Yi, J. Eng, A.J. Link, and H.L. Moses Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts Proteomics 10 2010 2458 2470
53. L. Zhong, J. Roybal, R. Chaerkady, W. Zhang, K. Choi, C.A. Alvarez, H. Tran, C.J. Creighton, S. Yan, R.M. Strieter, A. Pandey, and J.M. Kurie Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment Cancer Res. 68 2008 7237 7245
54. G.S. Butler, R.A. Dean, E.M. Tam, and C.M. Overall Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding Mol. Cell. Biol. 28 2008 4896 4914
55. G. Pocsfalvi, G. Votta, A. De Vincenzo, I. Fiume, D.A. Raj, G. Marra, M.P. Stoppelli, and I. Iaccarino Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc J. Proteome Res. 10 2011 5326 5337
56. K.H. Chiu, Y.H. Chang, Y.S. Wu, S.H. Lee, and P.C. Liao Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling J. Proteome Res. 10 2011 1110 1125
57. S. Makawita, C. Smith, I. Batruch, Y. Zheng, F. Ruckert, R. Grutzmann, C. Pilarsky, S. Gallinger, and E.P. Diamandis Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers Mol. Cell. Proteomics 10 2011 M111 (008599)
58. H. Xue, B. Lu, J. Zhang, M. Wu, Q. Huang, Q. Wu, H. Sheng, D. Wu, J. Hu, and M. Lai Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 9 2010 545 555
59. L. Yao, W. Lao, Y. Zhang, X. Tang, X. Hu, C. He, and L.X. Xu Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues J. Proteome Res. 11 2012 3281 3294
60. L. Yao, Y. Zhang, K. Chen, X. Hu, and L.X. Xu Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox PLoS One 6 2011 e24684
61. Y. Zhang, X. Tang, L. Yao, K. Chen, W. Jia, X. Hu, and L.X. Xu Lectin capture strategy for effective analysis of cell secretome Proteomics 12 2012 32 36
62. S. Liang, Z. Xu, X. Xu, X. Zhao, C. Huang, and Y. Wei Quantitative proteomics for cancer biomarker discovery Comb. Chem. High Throughput Screen. 15 2012 221 231
63. K.A. Neilson, N.A. Ali, S. Muralidharan, M. Mirzaei, M. Mariani, G. Assadourian, A. Lee, S.C. van Sluyter, and P.A. Haynes Less label, more free: approaches in label-free quantitative mass spectrometry Proteomics 11 2011 535 553
64. R.V. Polisetty, M.K. Gupta, S.C. Nair, K. Ramamoorthy, S. Tiwary, A. Shiras, G.R. Chandak, and R. Sirdeshmukh Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins J. Proteomics 74 2011 1918 1925
65. C.J. Yu, K.P. Chang, Y.J. Chang, C.W. Hsu, Y. Liang, J.S. Yu, L.M. Chi, Y.S. Chang, and C.C. Wu Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis J. Proteome Res. 10 2011 3778 3788
66. S.R. Piersma, U. Fiedler, S. Span, A. Lingnau, T.V. Pham, S. Hoffmann, M.H. Kubbutat, and C.R. Jimenez Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum J. Proteome Res. 9 2010 1913 1922
67. C.C. Wu, C.W. Hsu, C.D. Chen, C.J. Yu, K.P. Chang, D.I. Tai, H.P. Liu, W.H. Su, Y.S. Chang, and J.S. Yu Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas Mol. Cell. Proteomics 9 2010 1100 1117
68. Y. Ahn, U.B. Kang, J. Kim, and C. Lee Mining of serum glycoproteins by an indirect approach using cell line secretome Mol. Cells 29 2010 123 130
69. H. Zhang, X.J. Li, D.B. Martin, and R. Aebersold Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 21 2003 660 666 (Pubitemid 36638093)
70. P. Hagglund, J. Bunkenborg, F. Elortza, O.N. Jensen, and P. Roepstorff A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation J. Proteome Res. 3 2004 556 566 (Pubitemid 39207360)
71. J. Cao, C. Shen, H. Wang, H. Shen, Y. Chen, A. Nie, G. Yan, H. Lu, Y. Liu, and P. Yang Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach J. Proteome Res. 8 2009 662 672
72. J. Zhao, W. Qiu, D.M. Simeone, and D.M. Lubman N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis J. Proteome Res. 6 2007 1126 1138 (Pubitemid 46480476)
73. B. Tetu, and J. Brisson Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy Cancer 73 1994 2359 2365 (Pubitemid 24129120)
74. T.C. Lai, H.C. Chou, Y.W. Chen, T.R. Lee, H.T. Chan, H.H. Shen, W.T. Lee, S.T. Lin, Y.C. Lu, C.L. Wu, and H.L. Chan Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis J. Proteome Res. 9 2010 1302 1322
75. A. Bronisz, J. Godlewski, J.A. Wallace, A.S. Merchant, M.O. Nowicki, H. Mathsyaraja, R. Srinivasan, A.J. Trimboli, C.K. Martin, F. Li, L. Yu, S.A. Fernandez, T. Pecot, T.J. Rosol, S. Cory, M. Hallett, M. Park, M.G. Piper, C.B. Marsh, L.D. Yee, R.E. Jimenez, G. Nuovo, S.E. Lawler, E.A. Chiocca, G. Leone, and M.C. Ostrowski Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 Nat. Cell Biol. 14 2012 159 167
76. M. Korpal, B.J. Ell, F.M. Buffa, T. Ibrahim, M.A. Blanco, T. Celia-Terrassa, L. Mercatali, Z. Khan, H. Goodarzi, Y. Hua, Y. Wei, G. Hu, B.A. Garcia, J. Ragoussis, D. Amadori, A.L. Harris, and Y. Kang Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization Nat. Med. 17 2011 1101 1108
77. V. Kulasingam, Y. Zheng, A. Soosaipillai, A.E. Leon, M. Gion, and E.P. Diamandis Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer Int. J. Cancer 125 2009 9 14
78. G. Carbotti, A.M. Orengo, D. Mezzanzanica, M. Bagnoli, A. Brizzolara, L. Emionite, A. Puppo, M.G. Centurioni, M. Bruzzone, P. Marroni, A. Rossello, S. Canevari, S. Ferrini, M. Fabbi, Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors, Int. J. Cancer (in press).
79. S. Chaker, I. Kak, C.Macmillan, R. Ralhan, P.G.M.Walfish, Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a marker for thyroid cancer aggressiveness and disease-free survival, Thyroid (in press).
80. M. Ihnen, K. Kress, J.F. Kersten, E. Kilic, M. Choschzick, H. Zander, V. Muller, S. Mahner, F. Janicke, L. Woelber, and K. Milde-Langosch Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients BMC Cancer 12 2012 140
81. S. Minner, F. Kraetzig, M. Tachezy, E. Kilic, M. Graefen, W. Wilczak, C. Bokemeyer, H. Huland, G. Sauter, and T. Schlomm Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer Hum. Pathol. 42 2011 1946 1952
82. M. Tachezy, K. Effenberger, H. Zander, S. Minner, F. Gebauer, Y.K. Vashist, G. Sauter, K. Pantel, J.R. Izbicki, and M. Bockhorn ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients Int. J. Cancer 131 2012 396 405
83. M. Tachezy, H. Zander, F. Gebauer, A. Marx, J.T. Kaifi, J.R. Izbicki, and M. Bockhorn Activated leukocyte cell adhesion molecule (CD166) - its prognostic power for colorectal cancer patients J. Surg. Res. 177 2012 e15 e20
84. P.J. Boersema, T. Geiger, J.R. Wisniewski, and M. Mann Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples Mol. Cell. Proteomics 12 2012 158 171
85. L. Jin, Y. Zhang, H. Li, L. Yao, D. Fu, X. Yao, L.X. Xu, X. Hu, and G. Hu Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis Cell Res. 22 2012 1356 1373
86. J.Y. Wang, R. Tang, and J.M. Chiang Value of carcinoembryonic antigen in the management of colorectal cancer Dis. Colon Rectum 37 1994 272 277 (Pubitemid 24093768)
87. G.S. Karagiannis, C. Petraki, I. Prassas, P. Saraon, N. Musrap, A. Dimitromanolakis, and E.P. Diamandis Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis Oncotarget 3 2012 267 285
88. A. De Boeck, A. Hendrix, D. Maynard, M. Van Bockstal, A. Daniels, P. Pauwels, C. Gespach, M. Bracke, and O. De Wever Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression Proteomics 13 2012 379 388
89. A. Garcia-Lorenzo, A.M. Rodriguez-Pineiro, F.J. Rodriguez-Berrocal, M.P. Cadena, and V.S. Martinez-Zorzano Changes on the Caco-2 secretome through differentiation analyzed by 2-D differential in-gel electrophoresis (DIGE) Int. J. Mol. Sci. 13 2012 14401 14420
90. S. Mathivanan, H. Ji, B.J. Tauro, Y.S. Chen, and R.J. Simpson Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry J. Proteomics 76 2012 141 149 (Spec No.)
91. C.C. Wu, H.C. Chen, S.J. Chen, H.P. Liu, Y.Y. Hsieh, C.J. Yu, R. Tang, L.L. Hsieh, J.S. Yu, and Y.S. Chang Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 8 2008 316 332 (Pubitemid 351212330)
92. H.C. Diehl, K. Stuhler, S. Klein-Scory, M.W. Volmer, A. Schoneck, C. Bieling, W. Schmiegel, H.E. Meyer, and I. Schwarte-Waldhoff A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery Proteomics Clin. Appl. 1 2007 47 61
93. J.V. Weiss, S. Klein-Scory, S. Kubler, A. Reinacher-Schick, I. Stricker, W. Schmiegel, and I. Schwarte-Waldhoff Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP Int. J. Cancer 128 2011 1384 1392
94. H.T. Tan, J. Low, S.G. Lim, and M.C. Chung Serum autoantibodies as biomarkers for early cancer detection FEBS J. 276 2009 6880 6904
95. S. Klein-Scory, S. Kubler, H. Diehl, C. Eilert-Micus, A. Reinacher-Schick, K. Stuhler, B. Warscheid, H.E. Meyer, W. Schmiegel, and I. Schwarte-Waldhoff Immunoscreening of the extracellular proteome of colorectal cancer cells BMC Cancer 10 2010 70
96. Y. Yang, S.K. Lim, L.Y. Choong, H. Lee, Y. Chen, P.K. Chong, H. Ashktorab, T.T. Wang, M. Salto-Tellez, K.G. Yeoh, and Y.P. Lim Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins J. Proteome Res. 9 2010 4767 4778
97. A. Marimuthu, Y. Subbannayya, N.A. Sahasrabuddhe, L. Balakrishnan, N. Syed, N.R. Sekhar, T.V. Katte, S.M. Pinto, S.M. Srikanth, P. Kumar, H. Pawar, M.K. Kashyap, J. Maharudraiah, H. Ashktorab, D.T. Smoot, G. Ramaswamy, R.V. Kumar, Y. Cheng, S.J. Meltzer, J.C. Roa, R. Chaerkady, T.S. Prasad, H.C. Harsha, A. Chatterjee, and A. Pandey SILAC-based quantitative proteomic analysis of gastric cancer secretome Proteomics Clin. Appl. Nov 14 2012
98. S.Y. Hsieh, J.R. He, M.C. Yu, W.C. Lee, T.C. Chen, S.J. Lo, R. Bera, C.M. Sung, and C.T. Chiu Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis J. Proteome Res. 10 2011 4715 4724
99. A. Colli, M. Fraquelli, G. Casazza, S. Massironi, A. Colucci, D. Conte, and P. Duca Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review Am. J. Gastroenterol. 101 2006 513 523 (Pubitemid 43340927)
100. R. Yamashita, Y. Fujiwara, K. Ikari, K. Hamada, A. Otomo, K. Yasuda, M. Noda, and Y. Kaburagi Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry Mol. Cell. Biochem. 298 2007 83 92 (Pubitemid 46605286)
101. A. Slany, V.J. Haudek, H. Zwickl, N.C. Gundacker, M. Grusch, T.S. Weiss, K. Seir, C. Rodgarkia-Dara, C. Hellerbrand, and C. Gerner Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B J. Proteome Res. 9 2010 6 21
102. P. Maurya, P. Meleady, P. Dowling, and M. Clynes Proteomic approaches for serum biomarker discovery in cancer Anticancer. Res. 27 2007 1247 1255 (Pubitemid 46807270)
103. C.J. Yu, C.L. Wang, C.I. Wang, C.D. Chen, Y.M. Dan, C.C. Wu, Y.C. Wu, I.N. Lee, Y.H. Tsai, Y.S. Chang, and J.S. Yu Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology J. Proteome Res. 10 2011 4671 4682
104. X. Luo, Y. Liu, R. Wang, H. Hu, R. Zeng, and H. Chen A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer J. Proteomics 74 2011 528 538
105. C.I. Wang, C.L. Wang, C.W. Wang, C.D. Chen, C.C. Wu, Y. Liang, Y.H. Tsai, Y.S. Chang, J.S. Yu, and C.J. Yu Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome Int. J. Cancer 128 2011 2364 2372
106. Y.H. Chang, S.H. Lee, I.C. Liao, S.H. Huang, H.C. Cheng, and P.C. Liao Secretomic analysis identifies Alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells Mol. Cell. Proteomics 11 2012 1320 1339
107. Y.H. Chang, S.H. Lee, H.C. Chang, Y.L. Tseng, W.W. Lai, C.C. Liao, Y.G. Tsay, and P.C. Liao Comparative secretome analyses using a hollow fiber culture system with label-free quantitative proteomics indicates the influence of PARK7 on cell proliferation and migration/invasion in lung adenocarcinoma J. Proteome Res. 11 2012 5167 5185
108. J.R. Prensner, M.A. Rubin, J.T. Wei, and A.M. Chinnaiyan Beyond PSA: the next generation of prostate cancer biomarkers Sci. Transl. Med. 4 2012 127rv3
109. W.Z. Chen, B. Pang, B. Yang, J.G. Zhou, and Y.H. Sun Differential proteome analysis of conditioned medium of BPH-1 and LNCaP cells Chin. Med. J. 124 2011 3806 3809
110. D. Caccia, L. Zanetti Domingues, F. Micciche, M. De Bortoli, C. Carniti, P. Mondellini, and I. Bongarzone Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways J. Proteome Res. 10 2011 4196 4207
111. K.S. Selander, D.A. Brown, G.B. Sequeiros, M. Hunter, R. Desmond, T. Parpala, J. Risteli, S.N. Breit, and A. Jukkola-Vuorinen Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases Cancer Epidemiol. Biomark. Prev. 16 2007 532 537 (Pubitemid 46548657)
112. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, A.R. Bauskin, R.L. Ward, N.J. Hawkins, D.I. Quinn, P.J. Russell, R.L. Sutherland, S.N. Breit, C.A. Moskaluk, H.F. Frierson Jr., and G.M. Hampton Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc. Natl. Acad. Sci. U. S. A. 100 2003 3410 3415 (Pubitemid 36356597)